Relevance of clotting tests in liver disease

Postgraduate Medical Journal
J Thachil

Abstract

Liver disease is associated with impairment of the haemostatic function due to the abnormal and decreased synthesis of the clotting factors. It is thus only logical to have considered assessment of the clotting profile (to include prothrombin time (PT) and activated partial thromboplastin time (aPTT)) to be an integral part of the comprehensive assessment of a patient who presents with liver impairment. Laboratory abnormalities of coagulation are considered to be a predictive risk factor for bleeding, but patients with liver disease do not have bleeding pattern as those who have coagulation factor deficiencies. Recent experiments have cast doubts over the use of PT and aPTT as a marker of bleeding in liver disease and the use of such tests to decide the need for plasma replacement before interventions like liver biopsy. This article reviews the relevance of the clotting profile in liver disease, the other factors involved in the haemostatic failure associated with it, and the technical problems in the interpretation of these results. Most importantly, it stresses the need for more trials to help us guide the management of bleeding in patients with liver impairment.

Citations

Apr 27, 2013·European Journal of Clinical Pharmacology·Sebastian Harder, Jochen Graff
Dec 14, 2011·Hematology·Brian M Wicklund
Jun 4, 2014·Clinical Medicine : Journal of the Royal College of Physicians of London·Jecko Thachil
Jan 5, 2011·Autoimmune Diseases·Giulio DisantoJulia M Morahan
Nov 26, 2013·Critical Care Nursing Clinics of North America·Carole L Mackavey, Robert Hanks
Aug 12, 2009·Clinics in Laboratory Medicine·Valerie L Ng
May 6, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·M A EdensR P Stolk
Feb 10, 2012·Journal of Veterinary Emergency and Critical Care·Carrie KavanaghCynthia R L Webster
Oct 30, 2012·Journal of Critical Care·Horng-Ruey ChuaRinaldo Bellomo
Nov 15, 2011·The Veterinary Journal·Brigitte DircksReinhard Mischke
Sep 8, 2016·Systematic Reviews·Kate Elizabeth McCrossinGeorgina Imberger
Feb 16, 2018·Minerva anestesiologica·Ezeldeen AbuelkasemRaymond M Planinsic
Sep 17, 2010·Therapeutic Drug Monitoring·Edelgard Lindhoff-LastTheodore E Spiro
Dec 29, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Wenhua RenJun Wu
Jul 22, 2021·Artificial Organs·Dilmurodjon EshmuminovPierre-Alain Clavien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

The New England Journal of Medicine
Armando Tripodi, Pier Mannuccio Mannucci
Journal of Hepatology
Ton LismanCoagulation in Liver Disease Study Group
© 2022 Meta ULC. All rights reserved